Related references
Note: Only part of the references are listed.The predictive value of CD38 positive hepatic stellate cell count for assessing disease activity and fibrosis in patients with chronic hepatitis
Suad M. Abdeen et al.
ACTA HISTOCHEMICA (2009)
Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy
Rukhsana Gul et al.
CARDIOVASCULAR RESEARCH (2009)
NAADP mobilizes calcium from acidic organelles through two-pore channels
Peter J. Calcraft et al.
NATURE (2009)
Role of kidney ADP-ribosyl cyclase in diabetic nephropathy
Seon-Young Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
A novel signaling pathway of ADP-ribosyl cyclase activation by angiotensin II in adult rat cardiomyocytes
Rukhsana Gul et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Fabio Malavasi et al.
PHYSIOLOGICAL REVIEWS (2008)
NAADP: A Universal Ca2+ Trigger
Andreas H. Guse et al.
SCIENCE SIGNALING (2008)
Molecular mechanism of ADP-ribosyl cyclase activation in angiotensin II signaling in murine mesangial cells
Seon-Young Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule
Sandra March et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Inositol trisphosphate receptor Ca2+ release channels
J. Kevin Foskett et al.
PHYSIOLOGICAL REVIEWS (2007)
Second messenger function of nicotinic acid adenine dinucleotide phosphate revealed by an improved enzymatic cycling assay
Andreas Gasser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C
MW Russo et al.
LIVER TRANSPLANTATION (2005)
Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors α and β in activated rat hepatic stellate cells (HSC)
K Breitkopf et al.
CYTOKINE (2005)
Liver fibrosis
R Bataller et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
S Yokohama et al.
HEPATOLOGY (2004)
Medicinal chemistry and pharmacology of cyclic ADP-ribose
BVL Potter et al.
CURRENT MOLECULAR MEDICINE (2004)
Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II
R Bataller et al.
GASTROENTEROLOGY (2003)
An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells
N Kurikawa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Elevated expression of tyrosine kinase DDR2 in primary biliary cirrhosis
TK Mao et al.
AUTOIMMUNITY (2002)
NAADP mobilizes Ca2+ from reserve granules, lysosome-related organelles, in sea urchin eggs
GC Churchill et al.
CELL (2002)
Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver
G Paizis et al.
GASTROENTEROLOGY (2002)
Function of the 90-loop (Thr90-Glu100) region of staphylokinase in plasminogen activation probed through site-directed mutagenesis and loop deletion
G Rajamohan et al.
BIOCHEMICAL JOURNAL (2002)
Angiotensin-II type I receptor interaction is a major regulator for liver fibrosis development in rats
H Yoshiji et al.
HEPATOLOGY (2001)
Hepatic stellate cells as a target for the treatment of liver fibrosis
R Bataller et al.
SEMINARS IN LIVER DISEASE (2001)
Intracellular Ca2+ release mechanisms:: multiple pathways having multiple functions within the same cell type?
CP da Silva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2000)
Share Paper
